Hypertension management in patients with chronic kidney disease.
Hypertension is one of the major risk factors for the development and progression of chronic kidney disease. The loss of renal function leads to impaired renal autoregulation and renders the kidney vulnerable to the damaging effects of uncontrolled hypertension. Mounting evidence indicates that angiotensin-converting enzyme inhibitors and angiotensin receptor blockers slow the progression of chronic kidney disease through effects beyond lowering blood pressure. Studies are needed to determine whether high doses of the single agent or combination therapy is most effective in providing renal protection. Urinary protein excretion is a useful tool for monitoring and titrating therapy to maximize renal protection. Changes in the serum creatinine concentration and hyperkalemia are complications of antihypertensive therapy in patients with chronic kidney disease that can be successfully managed to allow continued use of renin-angiotensin blockade.
Palmer
Biff F
BF
Department of Medicine, Division of Nephrology, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390, USA. biff.palmer@utsouthwestern.edu
D000959:Antihypertensive Agents / Q000627:therapeutic use; D001794:Blood Pressure; D018450:Disease Progression; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000503:physiopathology / Q000517:prevention & control*; D011507:Proteinuria / Q000503:physiopathology / Q000517:prevention & control; D051436:Renal Insufficiency, Chronic / Q000209:etiology* / Q000503:physiopathology / Q000517:prevention & control*; D012084:Renin-Angiotensin System / Q000187:drug effects; D012307:Risk Factors; D000092502:Renin Inhibitors
D000959:Antihypertensive Agents; D000092502:Renin Inhibitors
Kidney Int. 2008 Apr;73(8):963-70
18272959
Kidney Int. 2007 Feb;71(3):188-90
17252027
J Am Soc Nephrol. 2008 Apr;19(4):743-8
18235083
Am J Nephrol. 2006;26(3):268-75
16763384
Am J Nephrol. 2008;28(3):381-90
18063856
Curr Opin Pharmacol. 2008 Apr;8(2):120-6
18308634
Am J Med Sci. 2004 Dec;328(6):330-43
15599329
Lancet. 2003 Jan 11;361(9352):117-24
12531578
J Am Soc Nephrol. 2003 Sep;14(9):2352-7
12937313
Am J Kidney Dis. 2006 Jul;48(1):8-20
16797382
Kidney Int. 2008 Jun;73(12):1419-25
18337712
Am J Kidney Dis. 2007 Jan;49(1):12-26
17185142
Ann Intern Med. 1996 Aug 1;125(3):201-4
8686978
Kidney Int. 2006 Sep;70(6):1000-7
16850026
Ann Intern Med. 2008 Jan 1;148(1):16-29
17984484
Diabetes Care. 2007 Jun;30(6):1577-8
17389334
N Engl J Med. 2004 Sep 23;351(13):1296-305
15385656
Am J Kidney Dis. 1993 Jul;22(1):188-95
8322782
Hypertension. 2001 Dec 1;38(6):E28-32
11751742
N Engl J Med. 2002 Oct 17;347(16):1256-61
12393824
Am J Kidney Dis. 2004 May;43(5 Suppl 1):S1-290
15114537
N Engl J Med. 2006 Jan 12;354(2):131-40
16407508
Ann Intern Med. 2008 Jan 1;148(1):30-48
17984482
J Am Soc Nephrol. 2003 Nov;14(11):2902-7
14569100
J Am Soc Nephrol. 2005 Feb;16(2):474-81
15615822
Nephrol Dial Transplant. 1998 Jul;13(7):1682-5
9681711
Am J Kidney Dis. 2008 Feb;51(2):199-211
18215698
Ann Intern Med. 1995 Nov 15;123(10):754-62
7574193
Am J Nephrol. 2007;27(3):287-93
17457028
J Am Soc Nephrol. 2007 Mar;18(3):960-6
17301190
Kidney Int. 2004 Jun;65(6):1991-2002
15149313
N Engl J Med. 2004 Aug 5;351(6):585-92
15295051
Curr Hypertens Rep. 2007 Nov;9(5):393-402
18177587
Am J Kidney Dis. 2002 Feb;39(2 Suppl 1):S1-266
11904577
Am J Kidney Dis. 1999 Aug;34(2):308-14
10430979
Am J Med Sci. 2001 Jun;321(6):388-400
11417753
Ann Intern Med. 2003 Aug 19;139(4):244-52
12965979
Kidney Int. 2007 Oct;72(7):879-85
17667984
Arch Intern Med. 2005 Apr 25;165(8):947-53
15851648
Clin J Am Soc Nephrol. 2006 Sep;1(5):1054-65
17699327